SRTA
Income statement / Annual
Last year (2025), Strata Critical Medical Inc.'s total revenue was $197.14 M,
a decrease of 20.73% from the previous year.
In 2025, Strata Critical Medical Inc.'s net income was -$15.65 M.
See Strata Critical Medical Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
09/30/2021 |
09/30/2020 |
09/30/2019 |
| Operating Revenue |
$197.14 M |
$248.69 M |
$225.18 M |
$146.12 M |
$50.53 M |
$23.43 M |
$31.20 M |
| Cost of Revenue |
$158.82 M
|
$189.77 M
|
$183.06 M
|
$123.85 M
|
$40.01 M
|
$21.11 M
|
$26.50 M
|
| Gross Profit |
$38.33 M
|
$58.92 M
|
$42.12 M
|
$22.28 M
|
$10.52 M
|
$2.33 M
|
$4.70 M
|
| Gross Profit Ratio |
0.19
|
0.24
|
0.19
|
0.15
|
0.21
|
0.1
|
0.15
|
| Research and Development Expenses |
$3.05 M
|
$3.18 M
|
$4.63 M
|
$5.55 M
|
$1.68 M
|
$861.00 K
|
$751.00 K
|
| General & Administrative Expenses |
$0.00
|
$81.71 M
|
$95.17 M
|
$62.51 M
|
$30.14 M
|
$9.29 M
|
$10.48 M
|
| Selling & Marketing Expenses |
$0.00
|
$7.95 M
|
$10.44 M
|
$7.75 M
|
$2.79 M
|
$2.53 M
|
$5.01 M
|
| Selling, General & Administrative Expenses |
$45.08 M
|
$89.66 M
|
$105.61 M
|
$70.26 M
|
$32.93 M
|
$11.83 M
|
$15.49 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$48.13 M
|
$92.85 M
|
$110.24 M
|
$75.80 M
|
$34.61 M
|
$12.69 M
|
$16.24 M
|
| Cost And Expenses |
$206.95 M
|
$282.62 M
|
$293.30 M
|
$199.65 M
|
$74.62 M
|
$33.79 M
|
$42.74 M
|
| Interest Income |
$4.24 M
|
$7.21 M
|
$8.44 M
|
$3.43 M
|
$460.00 K
|
$200.00 K
|
$703.00 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.00 K
|
$0.00
|
| Depreciation & Amortization |
$6.90 M
|
$5.96 M
|
$7.11 M
|
$5.73 M
|
$596.00 K
|
$526.00 K
|
$472.00 K
|
| EBITDA |
-$13.17 M |
-$21.60 M |
-$50.43 M |
-$22.31 M |
-$43.10 M |
-$9.83 M |
-$11.07 M |
| EBITDA Ratio |
-0.07
|
-0.09
|
-0.22
|
-0.15
|
-0.85
|
-0.42
|
-0.35
|
| Operating Income Ratio |
-0.05
|
-0.14
|
-0.3
|
-0.37
|
-0.48
|
-0.44
|
-0.37
|
| Total Other Income/Expenses Net |
-$10.26 M
|
$6.36 M
|
$10.58 M
|
$25.50 M
|
-$19.60 M
|
$199.00 K
|
$703.00 K
|
| Income Before Tax |
-$20.07 M
|
-$27.56 M
|
-$57.54 M
|
-$28.03 M
|
-$43.70 M
|
-$10.16 M
|
-$10.84 M
|
| Income Before Tax Ratio |
-0.1
|
-0.11
|
-0.26
|
-0.19
|
-0.86
|
-0.43
|
-0.35
|
| Income Tax Expense |
$0.00
|
-$255.00 K
|
-$1.47 M
|
-$772.00 K
|
-$3.64 M
|
$0.00
|
$0.00
|
| Net Income |
-$15.65 M
|
-$27.31 M
|
-$56.08 M
|
-$27.26 M
|
-$40.05 M
|
-$10.16 M
|
-$10.84 M
|
| Net Income Ratio |
-0.08
|
-0.11
|
-0.25
|
-0.19
|
-0.79
|
-0.43
|
-0.35
|
| EPS |
-0.19 |
-0.35 |
-0.76 |
-0.38 |
-0.57 |
-0.81 |
-1.47 |
| EPS Diluted |
-0.19 |
-0.35 |
-0.76 |
-0.38 |
-0.57 |
-0.81 |
-1.47 |
| Weighted Average Shares Out |
$82.45 M
|
$77.50 M
|
$73.52 M
|
$71.24 M
|
$70.10 M
|
$12.51 M
|
$7.36 M
|
| Weighted Average Shares Out Diluted |
$82.45 M
|
$77.50 M
|
$73.52 M
|
$71.24 M
|
$70.10 M
|
$12.51 M
|
$7.36 M
|
| Link |
|
|
|
|
|
|
|
